The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
92140155 9214015 5 F 20130222 20140409 20130405 20160912 EXP CH-CELGENEUS-151-21880-13030279 CELGENE 60.42 YR F Y 50.70000 KG 20160912 OT CH CH

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
92140155 9214015 1 PS REVLIMID LENALIDOMIDE 1 Oral DAY 1-21 Y U 21880 25 MG CAPSULES
92140155 9214015 2 SS REVLIMID LENALIDOMIDE 1 Oral DAY 1-21 Y U 21880 25 MG CAPSULES
92140155 9214015 3 SS REVLIMID LENALIDOMIDE 1 Oral Y U 21880 CAPSULES
92140155 9214015 4 SS Bendamustine BENDAMUSTINE 1 Intravenous drip DAY 1-2 Y U 0 115 MG INJECTION
92140155 9214015 5 SS Bendamustine BENDAMUSTINE 1 Intravenous drip DAY 1-2 Y U 0 115 MG SOLUTION
92140155 9214015 6 SS Bendamustine BENDAMUSTINE 1 Unknown Y U 0 UNKNOWN
92140155 9214015 7 SS DEXAMETHASONE. DEXAMETHASONE 1 Oral DAY 1+8+15+22 U U 0 40 MG TABLETS
92140155 9214015 8 SS CC-5013 LENALIDOMIDE 1 60100
92140155 9214015 9 SS REVLIMID LENALIDOMIDE 1 21880
92140155 9214015 10 C PARACETAMOL ACETAMINOPHEN 1 Oral 5000 IU (INTERNATIONAL UNIT) 0 4000 MG UNKNOWN QD
92140155 9214015 11 C TRIMETOPRIM W/SULFAMETOXAZOL 2 Oral 800MG/160MG 0 1 DF TABLETS TIW
92140155 9214015 12 C VALACICLOVIR VALACYCLOVIR HYDROCHLORIDE 1 Oral 0 1000 MG UNKNOWN QD
92140155 9214015 13 C DALTEPARIN DALTEPARIN 1 Subcutaneous 1000 MILLIGRAM 0 5000 IU UNKNOWN QD
92140155 9214015 14 C PAMIDRONATE PAMIDRONATE DISODIUM 1 Intravenous drip 0 30 MG UNKNOWN /month

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
92140155 9214015 1 Plasma cell myeloma
92140155 9214015 4 Plasma cell myeloma
92140155 9214015 7 Plasma cell myeloma
92140155 9214015 10 Bone pain
92140155 9214015 11 Antifungal prophylaxis
92140155 9214015 12 Antiviral prophylaxis
92140155 9214015 13 Thrombosis prophylaxis
92140155 9214015 14 Osteolysis

Outcome of event

Event ID CASEID OUTC COD
92140155 9214015 DE
92140155 9214015 HO
92140155 9214015 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
92140155 9214015 Febrile neutropenia
92140155 9214015 Neutrophil count decreased
92140155 9214015 Plasma cell myeloma
92140155 9214015 Platelet count decreased
92140155 9214015 Pneumonia
92140155 9214015 Transaminases increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
92140155 9214015 1 20130212 20130227 0
92140155 9214015 2 20130308 20130312 0
92140155 9214015 3 20130409 0
92140155 9214015 4 20130212 20130214 0
92140155 9214015 5 20130312 0
92140155 9214015 6 20130409 0
92140155 9214015 7 20130212 20130227 0
92140155 9214015 10 20121128 20130227 0
92140155 9214015 11 20130212 0
92140155 9214015 12 20130212 0
92140155 9214015 13 20130212 20130227 0
92140155 9214015 14 20120428 0